SMA-RL71

N/A

Report date: 2025/06/11 10:48:20
NME

Base Information

Drug NameSMA-RL71
Drug Alias NameNanomicelle-encapsulated RL71 (University of Otago)RL-71SMA-RL71
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Otago
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Otago
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A